Evidence map›Paper›PMID 39345299›Full record

ArticleClinical epidemiology2024

The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Project Cohort and Biobank from 2010 Through 2023-A Cohort Profile Update.

Frederik P B Kristensen, Sia K Nicolaisen, Jens S Nielsen, Diana H Christensen, Kurt Højlund, Henning Beck-Nielsen, Jørgen Rungby, Søren G Friborg, Ivan Brandslund, Jens S Christiansen and 9 more

Abstract read
In one paragraph

Article in Clinical epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Frederik P B KristensenDepartment of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0001-5311-8924
Sia K NicolaisenDepartment of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-6106-1945
Jens S NielsenSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.ORCID 0000-0003-3179-1186
Diana H ChristensenDepartment of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-2693-5651
Kurt HøjlundSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.
Henning Beck-NielsenSteno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.
Jørgen RungbySteno Diabetes Center Copenhagen, Herlev, Denmark.
Søren G FriborgDepartment of Endocrinology, Odense University Hospital, Odense, Denmark.
Ivan BrandslundDepartment of Biochemistry, Lillebaelt Hospital, Vejle, Denmark.ORCID 0000-0002-4203-5442
Jens S ChristiansenDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Peter VestergaardDepartment of Clinical Medicine and Endocrinology, Aalborg University Hospital, Aalborg, Denmark.
Niels JessenSteno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
Michael H OlsenDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Mette K AndersenNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.ORCID 0000-0001-8227-1469
Torben HansenNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, København, Denmark.ORCID 0000-0001-8748-3831
Charlotte BrønsSteno Diabetes Center Copenhagen, Herlev, Denmark.
Allan VaagSteno Diabetes Center Copenhagen, Herlev, Denmark.
Reimar W ThomsenDepartment of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0001-9135-3474
Henrik T SørensenDepartment of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0003-4299-7040

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This paper provides an overview of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort and biobank, including baseline characteristics of participants enrolled up to 2023, and post-enrollment rates of cardiovascular disease outcomes and mortality. Methods: Since 2010, the DD2 project has enrolled individuals with type 2 diabetes mellitus (T2DM) recently diagnosed by general practitioners and by hospital-based clinicians across Denmark. Data from questionnaires, clinical examinations, and biological samples are collected at enrollment. Additional baseline and longitudinal follow-up data are accessed via linkage to health registries. Results: Between 2010 and 2023, the DD2 project enrolled 11,369 participants (41.3% women, median age 61.4 years). Median T2DM duration at enrollment was 1.3 years, and median BMI was 31.6 kg/m Conclusion: The DD2 cohort, with its detailed information and long-term follow up, can improve our understanding of the progression and prevention of complications among individuals with newly diagnosed T2DM.

Indexed as

cohort profileDenmarkpatient characteristicstype 2 diabetes mellitus

Identifiers

PMID39345299
PMCPMC11439366

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.